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Endothelial dysfunction is seen in the earliest
stages of atherogenesis, before the appearance of
plaques, and is characterized in vivo with an impaired
endothelium-dependent vasodilatory response.1,2
Several studies have shown that normal endothelium-
dependent vasodilatation is mediated with nitric
oxide (NO) in response either to pharmacologic
stimuli, such as acetylcholine, bradykinins, and sub-
stance P, or to physiologic stimuli, which increase
blood flow or shear stress.3-5
In particular, endothelial dysfunction has been
noted in patients with both insulin-dependent and
noninsulin-dependent diabetes mellitus, thus indi-
rectly implicating either hyperglycemia or hyperinsu-
linemia as a possible mediator of abnormal endothe-
lium-dependent relaxation.6,7 Studies in hyper-
glycemic animals with hyperinsulinemia have shown
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impaired endothelial-dependent relaxation, which
suggests that elevated glucose levels may lead to
endothelial dysfunction with one or possibly several
mechanisms.8-10 Further evidence that supports the
role of hyperglycemia, and not hyperinsulinemia, in
endothelial dysfunction is lent from studies that
show that hyperinsulinemia with euglycemia poten-
tiates endothelium-dependent vasodilatation with
stimulation of NO release.11,12
In humans, the investigation of endothelial func-
tion has centered on either the macrocirculation or
the microvasculature. The recent development of
noninvasive techniques that can reliably quantify the
endothelial function has made it possible to study
factors that can damage the endothelium and cause
vascular disease.13,14 In this study, we have examined
the acute changes in the endothelial function of
both the macrocirculation and the microcirculation
related to the ingestion of a glucose load by healthy
subjects. On the basis of earlier studies, we have
hypothesized that acute hyperglycemia will lead to
impaired endothelial-dependent responses. 
MATERIAL AND METHODS
The study population consisted of 20 healthy sub-
jects (15 men, 5 women) aged 23 to 49 years (mean
± standard deviation of the mean, 32.3 ± 7.3 years).
All of the subjects were free of any illness, and no sub-
jects took any medications. All of the female subjects
were premenopausal. A special emphasis was given to
exclude anyone with active tobacco use or anyone
with a history of hypertension, diabetes mellitus,
hypercholesterolemia, any systemic illness, or the use
of any antihypertensive, cardiac, or hormonal medica-
tion. A history was taken, and then a physical exami-
nation and a fasting whole blood glucose measure-
ment were performed for all patients. Further details
for the study population are given in Table I.
The studies were performed in 2 separate tem-
perature-controlled rooms at 22°C. Each participant
was studied in the morning after an overnight fast
and after a 15-minute acclimation period in each
study room. The whole blood glucose levels were
measured in the fasting state, and at 30, 60, and 120
minutes after the oral ingestion of a standard 75-g
glucose load (Trutol 75, Custom Laboratories,
Baltimore, Md). All of the blood samples were
obtained with a capillary stick.
High-resolution brachial artery ultrasound scans,
consisting of images taken at rest and during reactive
hyperemia, were performed for each participant at
fasting conditions and were repeated 1 hour after
oral glucose ingestion. The scanning protocol is
described in detail elsewhere.13 In summary, the
brachial artery was scanned longitudinally at 2 to 10
cm above the elbow with a 10.0-MHz linear array
transducer and with an HDI Ultramark 9 system
(Advanced Technology Laboratories, Bothel, Wash).
Once the artery was located, the ultrasound scan
probe was kept stable at that point and subsequent
measurements were made at that location. The arte-
rial flow velocity was measured in the center of the
vessel with a Doppler scan at a 60-degree angle to
the blood flow. The electrocardiogram was moni-
tored and recorded simultaneously. After the mea-
surements were obtained at rest, a pneumatic
tourniquet was inflated to 50 mm Hg greater than
systolic pressure proximal to the target artery for 5
minutes and then deflated. Pulse Doppler scan trac-
ing was recorded for the first 15 seconds after the
cuff release and followed by a repeat 2-dimensional
scan for 90 seconds after the deflation.
We repeated the scanning protocol on a different
day after the patient had fasted at least 3 hours, with
a combination of both reactive hyperemia and sub-
lingual nitroglycerin, to determine the maximal dila-
tory capacity of the brachial artery and to exclude
that further dilatation after the glucose load was not
possible because the artery had reached its maximal
diameter. This maneuver combines the stimulation of
endothelium-dependent and endothelium-indepen-
dent mechanisms and provides the maximum nonin-
vasive vasodilatory stimulus. After resting measure-
ments were obtained, the tourniquet was inflated and
a 400-mg dose of nitroglycerin was administered
sublingually at 2 minutes after the cuff inflation. A
repeat duplex scan was obtained 3 minutes later,
immediately after the cuff deflation, as described
above.
The vessel diameter was measured with the NIH
Image computer program (National Institutes of
Health, Bethesda, Md). The diameter was measured
at the center of the vessel from the leading edge of
the echo of the near wall intima-lumen interface to
the leading edge of the echo of the far wall lumen-
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Table I. Subject characteristics
Characteristics No. of subjects
Age (years) 32.3 ± 7.3
Range 23-49
Weight (kg) 77.0 ± 10.9
Body mass index 25.0 ± 3.1
Systolic blood pressure (mm Hg) 115 ± 14
Diastolic blood pressure (mm Hg) 76 ± 8
Data expressed as mean ± standard deviation of the mean.
intima interface, coincident with the R wave on the
electrocardiogram. The artery diameter after reactive
hyperemia was measured at 60 seconds after the cuff
deflation in a similar fashion. The peak systolic veloc-
ity and the average velocity for the cardiac cycle were
calculated with the NIH Image and the Data Thief
computer program (National Institutes for Nuclear
Physics, Amsterdam, The Netherlands). Both veloci-
ties were measured for the first 4 cardiac cycles imme-
diately after the cuff deflation. The arterial diameter
and velocity measurements were all averaged for 4
cardiac cycles. The blood flow volume was calculated
using the type FV = (d/2)2 × p × AV × 60, whereas FV
is flow volume in cm3 × s–1, d is the artery diameter in
cm, p = 3.14, and AV, is the average blood flow
velocity in cm × s–1. We also calculated the average
velocity/artery diameter ratio (V/d) as a surrogate
measurement of shear stress, where shear stress =
8 h (V/d) ( h , viscosity; V, average velocity; and d,
diameter) or, in another form, shear stress =
4nQ/p r3 (n, viscosity; Q, flow; and r, diameter). A
satisfactory reproducibility and reliability has been
shown previously with this technique.13 In the pre-
sent study, all measurements were made indepen-
dently by 2 observers and the findings were correlat-
ed. This yielded a Spearman rank correlation coeffi-
cient of r = 0.96 for all measurements.
The forearm microcirculatory flow was measured
over the flexor surface at fasting conditions and at 1
hour after oral glucose ingestion. Single-point laser
Doppler scan measurements (Moor Instruments,
Devon, United Kingdom) were obtained during
iontophoresis and for 40 seconds before and 90 sec-
onds after iontophoresis. The 2 single-point probes
were placed within the delivery vehicle directly over
the skin. One probe was within the chamber that
contained acetylcholine and thus measured the
direct response to acetylcholine iontophoresis. The
second probe was placed outside of, but close (5
mm), to the chamber that contained acetylcholine
and thus measured the indirect response to acetyl-
choline. This indirect vasodilatory response is caused
by the acetylcholine sensitization of the nociceptors
and the release of substance P and, therefore, mea-
sures the axon reflex. Acetylcholine (1% in deionized
water) was delivered subdermally through the ion-
tophoresis chamber with an anodal current of 197
m A for 30 seconds (MIC 1, Moor Instruments).
Further details regarding this protocol have been
published elsewhere.15 Because the measurements in
our laboratory of 26 healthy subjects and of 21
patients with diabetes have shown a clear-cut dis-
tinction between the response obtained with the
iontophoresis of acetylcholine and that of deionized
water (increase over baseline, 1300% ± 275 vs 249 ±
116; P < .001) in the present study, we opted to test
only the response to the iontophoresis of acetyl-
choline and not that to the deionized water.
The vasodilatory response to heat was measured
on a different occasion at a postabsorptive phase.
The baseline flow was measured with the point
laser Doppler scan, and the flexor forearm skin
then was heated to 44°C with a brass heater (Moor
Instruments). The flow was measured again after
30 minutes, with the maximum response defined as
the ratio of the second measurement to the base-
line level. 
The statistical analysis was performed with the
Minitab computer software (State College, Penn)
with nonparametric tests. The Wilcoxon signed rank
test was used for the comparison of continuous vari-
ables before and after glucose ingestion. All of the
tests were 2-tailed, with significance taken as P <
.05. The variability between observers was calculat-
ed with a coefficient of variation, and their measure-
ments were correlated with the Spearman rank cor-
relation coefficient. The study was approved by the
Hospital Institutional Review Board, and consent
was obtained from all participants.
RESULTS
The blood glucose levels at baseline and at 2
hours after the glucose load ingestion were normal in
all subjects according to World Health Organization
criteria. The baseline glucose level was 4.75 ± 0.37
mmol/L (mean ± standard deviation of the mean)
and rose to 7.37 ± 0.96 at 30 minutes and 6.84 ±
1.38 at 60 minutes after glucose ingestion, but at 2
hours, it declined to 5.48 ± 1.00. The resting heart
rate was 61 ± 11 beats/min, and no significant
changes were found during any stage of the per-
formed experiments.
Changes in the macrocirculation. The results
of the brachial artery tests, both in percentage and
actual changes, are shown in Table II. During fast-
ing, the change in the brachial artery diameter in
response to reactive hyperemia was 11.7% (range,
8.3% to 14.3%; median, first and third quartile), and
after fasting, the glucose load was significantly
reduced to 4.2% (range, 1.5% to 9.6%; P < .001; Fig
1). The artery diameter at rest during fasting was
smaller as compared with the diameter after the glu-
cose ingestion (P < .02). The postinflation artery
diameter during fasting was slightly higher than the
diameter after the glucose load, but this increase did
not reach statistical significance (P = .2).
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The baseline peak and average blood flow veloc-
ities were similar during fasting and after glucose
ingestion (Table II). In contrast, both velocities dur-
ing the hyperemic response were higher after the
glucose load as compared with during fasting (P <
.05 for both). Similar changes were also found in the
V/d ratio, which did not differ at rest but was sig-
nificantly higher during the hyperemic response after
the glucose load as compared with during fasting (P
< .05). No differences were found in the resting and
maximum blood volume flow both at resting and
during reactive hyperemia before or after the glucose
ingestion. The percentage increase over the baseline
of both blood flow velocity and volume was also
similar in measurements taken before and after glu-
cose ingestion. 
The maximal vasodilatation, achieved with the
combination of both the hyperemic response (which
causes endothelium-dependent dilatation) and the
administration of sublingual nitroglycerin (which is
responsible for nonendothelium-dependent dilata-
tion), was measured in 9 participating subjects. The
results for this group of patients are shown in Table
III. The maximal artery diameter that was achieved
with the administration of nitroglycerin was signifi-
cantly higher than the hyperemic reaction that was
achieved after the glucose load (P < .05), and the
maximal blood velocity and the V/d ratio were
lower (P < .05 and < .02, respectively). 
Changes in the microcirculation. The results
from the microcirculation tests are shown in Table
IV. As a result of technical problems, analysis could
not be performed on the results of 3 subjects, so the
presented data have been obtained from the remain-
ing 17 participants. A significantly higher response
was obtained by iontophoresing acetylcholine dur-
ing fasting as compared with the response after the
administration of the glucose load [1293% (range,
591 to 1856) vs 863 (range, 385 to 1180); P < .01].
In contrast, no differences were found in the indi-
rect responses that depend on the function of the
local C-nociceptive fibers.
The baseline blood flux was slightly higher after
the ingestion of glucose as compared with the mea-
surements during fasting (P < .05), but the maxi-
mum flux did not show any differences. The
vasodilatory response to heat (975%; range, 572 to
1279) was similar to the response to acetylcholine
after the glucose load, but it was reduced when com-
pared with the response to acetylcholine on fasting
conditions (P < .05). No correlation was found
between the changes in blood glucose levels and the
vasodilatory response either in the microcirculation
or the macrocirculation.
DISCUSSION
The central finding of the present study is that
ingestion of 75 g of glucose by healthy subjects
impairs the endothelium-dependent vasodilatation
at both the macrocirculation (brachial artery, a con-
duit vessel) and the microcirculation (forearm skin)
levels. Because the endothelium is implicated in the
development of atheromatosis, the present results
may give an insight to the role of metabolic distur-
bances, such as hyperglycemia or hyperinsulinemia,
in the pathogenesis of both peripheral and cardiac
vascular disease. In addition, because vascular dys-
function is the leading cause of high morbidity and
mortality rates among patients with type 2 diabetes,
the presented data also suggest that the first changes
may start long before the clinical development of the
disease.
The role of the endothelium in maintaining the
vascular tone has been defined clearly since the dis-
covery that it is responsible for secreting NO—also
referred to as endothelial-derived relaxing factor,
which causes smooth muscle relaxation and vasodi-
latation.3,4 Accumulating evidence has shown that a
number of factors associated with the development
of atherosclerosis, including hypercholesterolemia,
smoking, type 1 or 2 diabetes, and menopause,
impair the endothelial function long before any clin-
ical manifestations are shown.6,7,13,16,17 Although
the exact mechanisms are not known, most of the
evidence points to a reduced secretion of NO.
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Fig 1. The endothelium-dependent vasodilatation was
reduced 60 minutes after the ingestion of 75 g of glucose
(dark area) when compared with fasting conditions (light
area) both at the brachial artery (*: P < .001) and at the
microcirculation of the forearm (¶: P < .002).
However, the possibility of an attenuated action of
the released NO cannot be excluded.18
The measurement of the diameter of the brachial
artery is a noninvasive technique that has been
shown to provide reliable information about the
endothelial function of the macrocirculation.13,16
According to recent studies, the brachial artery
vasodilatory response correlates well with the coro-
nary endothelium-dependent vasodilatation and,
therefore, provides a simple and useful method for
studying the development of the atherosclerosis.19
In brief, it is believed that the increase in blood flow
and in shear stress, which is related to reactive hyper-
emia, stimulates the endothelium to produce NO,
which in turn causes relaxation of the adjacent
smooth muscle cell and vasodilatation. Inhibition of
the NO production, either by pharmacologic means
in humans or by the removal of the endothelium in
dogs, has been shown to result in markedly impaired
dilatation.20,21 Our data show that despite an
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Table II. Results of changes in diameter, blood velocity, and blood flow in the brachial artery during fast-
ing conditions and 60 minutes after the ingestion of 75 g of glucose
During fasting (range) After glucose load (range) P-value
Brachial artery diameter (mm)
Resting 3.73 (3.37 to 4.01) 3.92 (3.51 to 4.31) <.02
During reactive hyperemia 4.22 (3.86 to 4.39) 4.17 (3.69 to 4.37) .28
Percent change 11.7 (8.3 to 14.3) 4.2 (1.5 to 9.6) <.001
Average velocity (cm/s2; one cardiac cycle)
Resting 11.7 (8.5 to 22.2) 14.5 (10.4 to 19.6) .29
During reactive hyperemia 110.8 (96.2 to 137.2) 127.5 (107.0 to 141.4) <.05
Percent change 780 (388 to 1277) 822 (429 to 1105) .29
Resting velocity/diameter ratio 28.93 (23.37 to 59.16) 35.85 (27.68 to 53.73) .32
Hyperemic velocity/diameter ratio 256.7 (245.2 to 306.2) 309.6 (254.8 to 399.5) <.05
Peak velocity (cm/s–1)
Resting 82.2 (70.5 to 99.3) 86.5 (74.8 to 108.2) .15
During reactive hyperemia 191.2 (164.3 to 220.8) 217.7 (201.3 to 245.3) <.05
Percent change 139.0 (82.4 to 181.3) 140.5 (108.6 to 174.3) .28
Blood flow (mL/s–1)
Resting 77 (53 to 160) 109 (70 to 155) .21
During reactive hyperemia 928 (739 to 1136) 1077 (692 to 1351) .08
Percent change 1106 (435 to 1503) 955 (525 to 1372) .48
Results expressed as median, first and third quartile.
Table III. Changes in brachial artery parameters during the sublingual nitroglycerin administration and
the ingestion of 75 g glucose in 9 subjects
During nitroglycerin 
administration (range) After glucose load (range) P-value
Brachial artery diameter (mm)
Resting 3.85 (3.66 to 4.30) 4.00 (3.62 to 4.25) .95
During reactive hyperemia 4.30 (4.13 to 4.80) 4.20 (4.08 to 4.39) <.05
Percent change 13.2 (5.5 to 16.6) 5.5 (2.2 to 10.5) <.05
Average velocity (cm/s–1; one cardiac cycle)
Resting 25.7 (9.0 to 34.8) 12.5 (9.7 to 17.8) .15
During reactive hyperemia 104.5 (74.0 to 148.6) 134.1 (115.0 to 167.0) <.02
Percent change 354 (177 to 1578) 854 (633 to 1257) .41
Resting velocity/diameter ratio 65.8 (25.6 to 80.9) 30.23 (28.20 to 46.38) .19
Hyperemic velocity/diameter ratio 243.0 (173.9 to 343.7) 316.6 (271.6 to 380.2) <.02
Peak velocity (cm/s–1)
Resting 91.2 (72.3 to 102.0) 85.2 (70.7 to 104.4) .80
During reactive hyperemia 190.2 (126.8 to 271.0) 219.1 (197.6 to 276.7) <.05
Percent change 1168 (428 to 1655) 1620 (1200 to 1997) .08
Blood flow (mL/s–1)
Resting 183.9 (589 to 1292) 99.9 (902 to 1469) .12
During reactive hyperemia 1072 (589 to 1292) 1147 (902 to 1469) .08
Percent change 518 (248 to 2255) 939 (743 to 1486) .55
Results expressed as median, first and third quartile.
increased blood velocity during reactive hyperemia,
the artery diameter did not increase after the admin-
istration of the glucose load (4.22 mm vs 4.17 mm;
P = .28), which indicates that the endothelium-
dependent vasodilatation was inappropriate. This
failure for vasodilation resulted in a higher V/d
ratio, which can be used as a surrogate measurement
of shear stress because no changes in the viscosity
would be expected in such a short period.
The most reasonable explanation for this finding
is that the glucose load has an inhibitory effect on the
endothelial function that prevents full vasodilatation.
However, the mechanisms that are responsible for
the above changes are not well understood. Insulin is
known to increase the NO production. Therefore,
the hyperinsulinemia that results from the glucose
ingestion is probably accountable for the increased
resting brachial artery diameter and erythrocyte flux
60 minutes after the administration of the glucose
load, as compared with resting conditions during
fasting.22 It can also be argued that the vasodilatation
related to the hyperemic response after the glucose
load was not higher because the maximal ability of
the vessel to dilate had already been reached. To
exclude such a possibility, we measured the vasodi-
latation from a combined endothelium-dependent
and endothelium-independent stimulation that was
tested on a different day from that of the glucose tol-
erance test. Our results showed that under these cir-
cumstances a higher diameter and reduced velocity
were achieved, which resulted in a lower V/d ratio.
Therefore, the inability for vasodilation is functional
and may be the prodrome to the arterial stiffness that
is found in patients without diabetes with glucose
levels close to the higher normal limits.23 In addition,
no changes were noticed in the heart rate or in the
volume of the blood flow, which thus excluded car-
diac output or other nonspecific factors as being
responsible for the observed differences. Finally, we
think that no important changes should be expected
in the blood viscosity from the small increase in the
blood glucose levels after the administration of the
glucose load; therefore, the V/d ratio is a valid sur-
rogate measurement of the shear stress.
Although we could not specifically exclude the
hyperosmotic effect of hyperglycemia as a contribut-
ing factor to the impaired endothelium-dependent
responses, recent evidence suggests that hyperosmo-
larity alone is probably not significant. In animal
models, aortic rings exposed to elevated glucose
concentrations failed to dilate in response to acetyl-
choline, whereas aortae incubated with mannose as
a hyperosmotic control displayed normal acetyl-
choline-induced vasodilation.24 Moreover, the addi-
tion of exogenous L-arginine as a NO donor causes
an increase in flow-mediated coronary artery vasodi-
latation in the presence of hyperglycemia but not in
the hyperosmotic controls.25 With the data taken
together, we believe that the data of the present
study also suggest that the effect on endothelium-
dependent responses is the result of hyperglycemia
and probably not hyperosmolarity alone. 
Impairment of the microcirculation with diabetes
is strongly related to the development of long-term
complications.26 However, methodologic problems
have hampered the evaluation of the endothelial func-
tion in this part of the circulation. Iontophoresis of
acetylcholine is probably the most effective and reli-
able noninvasive method available, and recent studies,
both from our laboratory and from other investiga-
tors, have shown impaired endothelium-dependent
vasodilatation in patients with diabetes.15,27 In this
study, we found that the endothelial function in the
microcirculation is affected by glucose, which is simi-
lar to the following changes observed in the macro-
circulation: under resting conditions, the erythrocyte
flux after the glucose ingestion was higher as com-
pared with during fasting, which indicated vasodilata-
tion, but the percentage increase over baseline after
the iontophoresis of acetylcholine was reduced. 
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Table IV. Changes in the forearm microcirculation during fasting conditions and after the glucose load
During fasting (range) After glucose load (range) P-value
Skin erythrocyte flux (V)
Resting 9.4 (5.8 to 13.2) 13.3 (9.9 to 17.5) <.05
After acetylcholine iontophoresis 102.9 (90.6 to 123.9) 108.7 (71.9 to 146.7) .92
Percent change 1293 (591 to 1856) 863 (385 to 1180) <.01
Nerve axon reflex related flux (V)
Resting 13.2 (11.6 to 21.2) 16.7 (11.5 to 20.5) .12
After acetylcholine iontophoresis 73.5 (47.7 to 98.2) 65.9 (51.4 to 100) .89
Percent change 386 (231 to 615) 412 (199 to 526) .49
Results expressed as median, first and third quartile.
In an effort to prove that the reduced percentage
increase over baseline after the administration of the
glucose load was not caused by the inability of the
microcirculation to further increase the flux, we also
measured the vasodilatory response related to the
nerve axon reflex and to heat. Our data indicate that
the vasodilatory response to heat is similar to that of
the administration of the glucose load, but lower
than the response during fasting, and that the nerve
axon reflex-related response is similar during fasting
and after the administration of the glucose load. We
believe that these results indicate again that the
observed differences are related to functional
changes rather than anatomic restrictions.
A variety of possible pathways, other than the NO
pathway, have been described as causing both vasodi-
latation and vasoconstriction.28 Experimental studies
in animals with diabetes have indicated that 
the abnormal endothelial production of vasoconstric-
tor prostanoids, notably thromboxane A2 and
prostaglandin H2, may be a cause of endothelial cell
dysfunction. To exclude the effect of these vasoactive
prostanoids, previous investigators have administered
aspirin to their subjects to inhibit the cyclooxygen-
ase-mediated vasoconstriction.29 However, more
recent studies have shown that the attenuated
endothelium-dependent vasodilation in patients with
diabetes is not affected by pretreatment with
cyclooxygenase inhibitors.30 Therefore, we opted not
to administer aspirin.
The present study, which examined the effects of
a glucose load on the microcirculation, indicates that
macrocirculation and microcirculation vascular
changes have a common origin and may explain the
coexistence of both atherosclerosis and nephropathy
and retinopathy in patients with type 2 diabetes mel-
litus. Because the impairment of endothelial respons-
es is associated with the early changes of atheroscle-
rosis, it is possible that prolonged hyperglycemia and
endothelial dysfunction may lead to the early and
accelerated atherosclerosis of diabetes. The aggres-
sive control of hyperglycemia also has been shown to
prevent the microvascular complications of dia-
betes,31 which may be caused by the effects of hyper-
glycemia on the microcirculation. 
In summary, we have shown that in healthy sub-
jects the endothelial function is impaired at both the
microcirculation and the macrocirculation after the
ingestion of a glucose load. Despite an initial vasodi-
latation at rest, the maximal flow–dependent dilata-
tion is inappropriate leading to increased blood flow
velocity. Further longitudinal studies are necessary
to investigate the long-term effects of constant
hyperglycemia on the endothelium function and the
possible contribution of this disturbance in the
development of atherosclerosis.
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